Reporting owner · CIK 0002004380

Lippis Daniel J.

Visual SEC Form 4 history across 1 companies, 15 transactions and 5 filings.

CVP, TAVRCVP, TAVREdwards Lifesciences Corp
Open-market mix
Latest filingSep 11, 2026, 11:15 PM
Filings5Form 4 records
Buying$00 purchases
Selling$154.5K4 sales
Net value−$154.5KBuys minus sells
Companies12 securities
Most recentSep 11, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-51Jan 251Feb 251Mar 251Sep 26

Net value flow

Buys minus sells

Jan 25
−$34.4K
Feb 25
−$38.2K
Mar 25
−$27.8K
Sep 26
−$54.2K

Transaction texture

Ownership and ticket size

Average P/S size$38.6K
Median P/S size$36.3K
Direct15
Indirect0
Sep 11, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern3Derivative Transactionfiling-context3Direct Ownershipfiling-context12Large Holdings Reductionholdings310b5-1 Detectedfiling-context9

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Edwards Lifesciences Corp on Sep 11, 2026 valued at $54,169.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Edwards Lifesciences Corp on Sep 11, 2026 valued at $54,169.

Review SEC filing

Associated companies

Visual map of known reporting history

EWEdwards Lifesciences Corp15 transactions · latest Sep 11, 2026, 11:15 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
EWLippis Daniel J.
CVPTAVR
exercise10b5-1619$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
0.0%09/1109/11
EWLippis Daniel J.
CVPTAVR
sale10b5-1619-$5.41MS
Cluster Selling Direct Ownership 10b5-1 Detected
0.0%09/1109/11
EWLippis Daniel J.
CVPTAVR
exercise10b5-1619$4.49MM
Direct Ownership 10b5-1 Detected
0.0%09/1109/11
EWLippis Daniel J.
CVPJAPAC
exercise10b5-1400$0M
Derivative Transaction Direct Ownership Large Holdings Reduction+1
—03/10/202503/10/2025
EWLippis Daniel J.
CVPJAPAC
sale10b5-1400-$2.77MS
Cluster Selling Direct Ownership 10b5-1 Detected
—03/10/202503/10/2025
EWLippis Daniel J.
CVPJAPAC
exercise10b5-1400$1.81MM
Direct Ownership 10b5-1 Detected
—03/10/202503/10/2025
EWLippis Daniel J.
CVPJAPAC
withholding222-$1.69MF
Direct Ownership
—02/18/202502/18/2025
EWLippis Daniel J.
CVPJAPAC
withholding165-$1.25MF
Direct Ownership
—02/18/202502/17/2025
EWLippis Daniel J.
CVPJAPAC
withholding214-$1.63MF
Direct Ownership
—02/18/202502/16/2025
EWLippis Daniel J.
CVPJAPAC
exercise10b5-1500$0M
Derivative Transaction Direct Ownership Large Holdings Reduction+1
—02/13/202502/13/2025

Lippis Daniel J. Insider Activity FAQ

SEC Form 4 context

Who is Lippis Daniel J.?

Lippis Daniel J. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002004380.

Which companies has Lippis Daniel J. reported transactions for?

Edwards Lifesciences Corp

When was Lippis Daniel J.'s latest insider buy?

No open-market insider purchase is available for this period.

When was Lippis Daniel J.'s latest insider sale?

sale at Edwards Lifesciences Corp on Sep 11, 2026 valued at $54,169.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.